FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081969572> ?p ?o ?g. }

• W2081969572 endingPage "1316" @default.
• W2081969572 startingPage "1316" @default.
• W2081969572 abstract "We read with interest the report by Blum et al.1 about acute myeloid leukemia (AML) with t(6;11)(q27;q23). The recent update of our data base gives us the opportunity to collect data on this rare entity. Over a 17-year period (1984–2001) the BGMT intergroup (the Hematology Departments from Bordeaux, Grenoble, Marseille, Toulouse, and [later] Montpellier; France) entered 1007 patients (ages 15–60 years) on 4 consecutive, prospective, randomized trials.2-4 Only seven patients ultimately were lost to follow-up. Of the remaining 1000 evaluable patients, cytogenetics were available for 766 patients, and we found 6 patients with t(6;11)(q27;q23). Two of 6 patients (gender ratio = 1) had gingival involvement, 1 of 6 patients had leukemia cutis, and 1 of 6 patients had lymphadenopathy and splenomegaly. The median patient age was 39 years (range, 25–55 years), and all patients presented with French–American–British subtype M4 disease (2 of 6 patients) or subtype M5 disease (4 of 6 patients). The median white blood cell (WBC) count was 7 × 109/L (range, 3–180 × 109/L), and only 1 patient had a WBC count > 10 × 109/L. The t(6;11) was observed as a sole change in 2 patients, was associated with trisomy 21 in 2 other patients (1 patient also had an extra copy of the derivative 6), and with a structural change in the 2 other patients. Therefore, the karyotype was complex in only one patient (three abnormalities). A complete remission (CR) was achieved in four of six patients, in two courses for two of them. All patients who achieved a CR developed recurrences after a median of 12 months (range, 4–19 months). Death occurred in all patients a median of 12 months after diagnosis (range, 1–47 months), resulting in a 14-month median survival duration and a 2-year Kaplan–Meier survival rate of 17% (95% confidence interval, 0–46%). Our data were very consistent with those of Blum et al. and confirm the poor prognosis for adults with t(6;11) AML for whom investigational approaches had to be considered. Eric Jourdan M.D.*, Nicole Dastugue M.D. , * Division of Hematology, Department of Internal Medicine, Hôpital Caremeau, Nimes, France, Department of Genetics, Hôpital Purpan, Toulouse, France." @default.
• W2081969572 created "2016-06-24" @default.
• W2081969572 creator A5032553284 @default.
• W2081969572 creator A5037888163 @default.
• W2081969572 date "2005-01-01" @default.
• W2081969572 modified "2023-09-27" @default.
• W2081969572 title "Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): Results from Cancer and Leukemia Group B study 8461 and review of the literature" @default.
• W2081969572 cites W2151367307 @default.
• W2081969572 cites W3202465254 @default.
• W2081969572 doi "https://doi.org/10.1002/cncr.20931" @default.
• W2081969572 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15700268" @default.
• W2081969572 hasPublicationYear "2005" @default.
• W2081969572 type Work @default.
• W2081969572 sameAs 2081969572 @default.
• W2081969572 citedByCount "13" @default.
• W2081969572 countsByYear W20819695722012 @default.
• W2081969572 countsByYear W20819695722013 @default.
• W2081969572 countsByYear W20819695722015 @default.
• W2081969572 countsByYear W20819695722016 @default.
• W2081969572 countsByYear W20819695722017 @default.
• W2081969572 countsByYear W20819695722021 @default.
• W2081969572 countsByYear W20819695722022 @default.
• W2081969572 crossrefType "journal-article" @default.
• W2081969572 hasAuthorship W2081969572A5032553284 @default.
• W2081969572 hasAuthorship W2081969572A5037888163 @default.
• W2081969572 hasBestOaLocation W20819695721 @default.
• W2081969572 hasConcept C121608353 @default.
• W2081969572 hasConcept C126322002 @default.
• W2081969572 hasConcept C194409129 @default.
• W2081969572 hasConcept C2776229224 @default.
• W2081969572 hasConcept C2776976509 @default.
• W2081969572 hasConcept C2778461978 @default.
• W2081969572 hasConcept C2778488018 @default.
• W2081969572 hasConcept C2778729363 @default.
• W2081969572 hasConcept C54355233 @default.
• W2081969572 hasConcept C71924100 @default.
• W2081969572 hasConcept C86803240 @default.
• W2081969572 hasConcept C90924648 @default.
• W2081969572 hasConceptScore W2081969572C121608353 @default.
• W2081969572 hasConceptScore W2081969572C126322002 @default.
• W2081969572 hasConceptScore W2081969572C194409129 @default.
• W2081969572 hasConceptScore W2081969572C2776229224 @default.
• W2081969572 hasConceptScore W2081969572C2776976509 @default.
• W2081969572 hasConceptScore W2081969572C2778461978 @default.
• W2081969572 hasConceptScore W2081969572C2778488018 @default.
• W2081969572 hasConceptScore W2081969572C2778729363 @default.
• W2081969572 hasConceptScore W2081969572C54355233 @default.
• W2081969572 hasConceptScore W2081969572C71924100 @default.
• W2081969572 hasConceptScore W2081969572C86803240 @default.
• W2081969572 hasConceptScore W2081969572C90924648 @default.
• W2081969572 hasIssue "6" @default.
• W2081969572 hasLocation W20819695721 @default.
• W2081969572 hasLocation W20819695722 @default.
• W2081969572 hasOpenAccess W2081969572 @default.
• W2081969572 hasPrimaryLocation W20819695721 @default.
• W2081969572 hasRelatedWork W2030349286 @default.
• W2081969572 hasRelatedWork W2042598277 @default.
• W2081969572 hasRelatedWork W2092834412 @default.
• W2081969572 hasRelatedWork W2407386140 @default.
• W2081969572 hasRelatedWork W2613559762 @default.
• W2081969572 hasRelatedWork W2740622639 @default.
• W2081969572 hasRelatedWork W2952491561 @default.
• W2081969572 hasRelatedWork W2995226478 @default.
• W2081969572 hasRelatedWork W3175260673 @default.
• W2081969572 hasRelatedWork W3183067027 @default.
• W2081969572 hasVolume "103" @default.
• W2081969572 isParatext "false" @default.
• W2081969572 isRetracted "false" @default.
• W2081969572 magId "2081969572" @default.
• W2081969572 workType "article" @default.